Literature DB >> 29700020

Cancer and the heart.

Rebecca Dobson1, David J Wright1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29700020      PMCID： PMC5916056          DOI： 10.3399/bjgp18X695861

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

Review 1.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Authors:  Hui-Ming Chang; Tochukwu M Okwuosa; Tiziano Scarabelli; Rohit Moudgil; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

Review 2.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.

Authors:  Hui-Ming Chang; Rohit Moudgil; Tiziano Scarabelli; Tochukwu M Okwuosa; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

3.  Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Gaia De Giacomi; Mara Rubino; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

4.  Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.

Authors:  G Curigliano; D Cardinale; T Suter; G Plataniotis; E de Azambuja; M T Sandri; C Criscitiello; A Goldhirsch; C Cipolla; F Roila
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 5.  Cardiac toxicity in cancer survivors.

Authors:  Daniel J Lenihan; Stefano Oliva; Eric J Chow; Daniela Cardinale
Journal:  Cancer       Date:  2013-06-01       Impact factor: 6.860

Review 6.  Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.

Authors:  Edward T H Yeh; Courtney L Bickford
Journal:  J Am Coll Cardiol       Date:  2009-06-16       Impact factor: 24.094

7.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Authors:  Jose Luis Zamorano; Patrizio Lancellotti; Daniel Rodriguez Muñoz; Victor Aboyans; Riccardo Asteggiano; Maurizio Galderisi; Gilbert Habib; Daniel J Lenihan; Gregory Y H Lip; Alexander R Lyon; Teresa Lopez Fernandez; Dania Mohty; Massimo F Piepoli; Juan Tamargo; Adam Torbicki; Thomas M Suter
Journal:  Eur Heart J       Date:  2016-08-26       Impact factor: 29.983

Review 8.  Mechanisms of adverse effects of anti-VEGF therapy for cancer.

Authors:  T Kamba; D M McDonald
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.